| Date | Title | Description |
| 20.08.2026 | Network Bio Launches with $50 Million Financing |
PALO ALTO, CA, Network Bio, a biotechnology company, launched with $50 million in financing.
>> Click here for more funding data on Network Bio
>> To export Network Bio funding data to PDF and Excel, click here
Network Bio, a b... |
| 20.08.2026 | Network Bio Launches With $50 Million Financing And $30+ Million AI Partnership To Build Disease-Specific Models | Network Bio has launched with $50 million in financing to build disease-specific artificial intelligence models trained on large-scale human tissue, blood, molecular and clinical datasets, as the biotechnology company seeks to apply AI to d... |
| 19.08.2026 | Network Bio Raises $50M in Funding | Network Bio, a Boston, MA-based biotechnology company building disease-specific AI models from human biological data, raised $50M in financing.
Backers included Section 32, Thiel Bio, Founders Fund, Breyer Capital, Blue Venture Fund, JSL He... |
| 19.08.2026 | Network Bio Raises $50M to Expand Disease-Specific AI Platform | Network Bio Raises $50M for AI Research
Network Bio has raised $50 million in financing to expand its biotechnology and artificial intelligence platform. The round includes Section 32, Thiel Bio, Founders Fund and Breyer Capital. Blue Ventu... |
| 21.02.2026 | Digital Mental Health Pioneer Secures $23.7M to Transform Care Access | Big Health raised $23.7 million. This funding will scale its FDA-cleared digital mental health treatments. SleepioRx targets insomnia. DaylightRx addresses generalized anxiety. A recent Centers for Medicare & Medicaid Services policy ch... |
| 15.02.2026 | Big Health Secures $23.7 Million To Scale FDA-Cleared Treatments | Big Health announced it has secured $23.7 million in new strategic funding to accelerate the adoption of its FDA-cleared digital mental health treatments, as health systems increasingly integrate reimbursable digital care into routine pract... |
| 12.02.2026 | Big Health Raises $23.7M in New Funding | Big Health, a San Francisco, CA-based developer of digital treatments for mental health conditions, raised $23.7M in new funding.
The round was led by .406 Ventures and AlleyCorp, with participation from CVS Health Ventures, Blue Venture Fu... |
| 28.01.2026 | Origin Raises Series B Funding | Origin, a Los Angeles, CA-based provider of pelvic floor physical therapy and whole-body musculoskeletal (MSK) care for women, raised an undisclosed amount in Series B funding.
The round was led by SJF Ventures with participation by Blue Ve... |
| 28.01.2026 | Origin: Series B Funding Raised To Expand Insurance-Covered Pelvic Floor Physical Therapy Nationwide | Origin, a national provider of pelvic floor physical therapy and women’s musculoskeletal care, said it has secured Series B funding to expand access to pelvic health services through a hybrid model combining virtual care with in-person clin... |
| 29.09.2025 | Daymark Health Secures $20M to Redefine Cancer Care | Daymark Health secured $20M in Series A funding. Healthier Capital and Blue Venture Fund led the round. This investment scales Daymark's value-based cancer care platform. The company revolutionizes cancer treatment, offering integrated supp... |
| 28.09.2025 | Daymark Health: $20 Million Series A Closed For Scaling Cancer Care Platform | Daymark Health, a company dedicated to transforming the cancer care experience for patients, healthcare providers, and health plans, has completed a significant Series A funding round, raising $20 million. This crucial investment was led by... |
| 26.09.2025 | Daymark Health Secures $20M to Scale Value-Based Cancer Care | What You Should Know:
– Daymark Health, a company dedicated to redefining the cancer care experience secures $20M in Series A funding round led by Healthier Capital and Blue Venture Fund, with continued participation from existing investors... |
| 25.09.2025 | Daymark Health Raises $20M in Series A Funding | Daymark Health, a Philadelphia, PA-based cancer care company, raised $20M in Series A funding.
The round was led by Healthier Capital and Blue Venture Fund, with participation from existing investors including Yosemite, Maverick Ventures, a... |
| 11.09.2025 | Octave Bioscience Secures Major Funding for Precision Neurology Advancement | Octave Bioscience secured $51.1 million in fresh capital. This includes a $35.6 million Series C equity round and a $15.5 million debt facility. Funds accelerate MSDA test commercialization. This blood-based diagnostic tool measures Multipl... |
| 10.09.2025 | Octave Bioscience: $35 Million Raised For Advancing Precision Care For Neurological Diseases | Octave Bioscience, a company focused on precision medicine for neurodegenerative conditions, has announced the successful close of a $35.6 million Series C equity financing round. In addition to this funding, the company has secured a $15.5... |
| 05.09.2025 | Octave Bioscience Raises $35M in Series C Financing | Octave Bioscience, a Menlo Park, CA-based commercial stage precision care company, announced the close of its $35.6M Series C equity financing and that it has entered into a $15.5M non-dilutive term loan agreement with Silicon Valley Bank (... |
| 02.09.2025 | Noctrix Health Raises Up To $33.5M in Debt and Equity Funding | Noctrix Health, a Pleasanton, CA-based developer of the Nidra Tonic Motor Activation (TOMAC) therapy for Restless Legs Syndrome (RLS), raised up to $33.5M in debt and equity funding.
Backers included Blue Venture Fund, and Sandbox Clinical ... |
| 25.08.2025 | Nest Health: Over $12.5 Million Series A Secured For Expanding In-Home Family Care Model For Medicaid | Nest Health, a pioneering provider of in-home and whole-family care for Medicaid families, has secured over $12.5 million in Series A funding. The round was co-led by returning investors 8VC and Blue Venture Fund, with additional participat... |
| 31.07.2025 | Ultromics Secures $55M to Revolutionize Heart Disease Diagnosis with AI | Ultromics, a leader in AI-driven cardiology, secured $55 million in Series C funding. This significant investment propels its mission to transform heart disease diagnosis. The company's EchoGo® platform utilizes advanced AI. It analyzes sta... |
| 31.07.2025 | Ultromics Secures $55M to Expand AI-Driven Cardiology Solutions for Heart Failure | What You Should Know:
– Ultromics, a pioneer in AI-driven cardiology solutions secures $55M in Series C financing co-led by L&G, Allegis Capital, and Lightrock, with continued support from Oxford Science Enterprises, GV, Blue Venture Fu... |
| 31.07.2025 | Ultromics raises $55M Series C to scale AI-driven heart failure detection | Oxford-based Ultromics, a pioneer in AI-driven cardiology diagnostics solutions, has raised $55 million through its Series C funding round.
Ultromics has developed the first FDA-cleared, Medicare-reimbursed AI technology designed to help cl... |
| 31.07.2025 | Ultromics Raises $55M in Series C Funding | Ultromics, an Oxford, UK-based company which specializes in AI-driven cardiology solutions, raised $55M in Series C funding.
The round was led by L&G, Allegis Capital and Lightrock, with continued support from Oxford Science Enterprises... |
| 19.11.2024 | Fort Health: $5.5 Million Raised For Expanding Mental Health Care Services | Fort Health, a leader in integrated behavioral health, announced that it has raised $5.5 million to expand mental health care to more pediatricians’ offices. Twelve Below and Vanterra led this funding round, bringing the total amount raised... |
| 25.06.2024 | Humata Health: $25 Million Funding Raised To Create Frictionless Prior Authorization For Providers/Payers | Humata Health, a company creating frictionless prior authorizations for payers and providers with AI and automation, announced that it closed a $25 million investment. This funding round was led by Blue Venture Fund (representing the majori... |
| 20.06.2024 | Humata Health Secures $25M for AI-Powered Prior Authorization | What You Should Know:
– Humata Health, a company revolutionizing prior authorizations in healthcare with AI and automation raises $25M co-led by Blue Venture Fund and LRVHealth with participation from Optum Ventures, .406 Ventures, Highmark... |
| 23.05.2024 | Tuesday Health Launches Supportive Care Solution with $60M | What You Should Know:
– Tuesday Health, a leader in value-based care for the seriously ill, has launched its innovative supportive care solution with $60M in partnership with Valtruis, Blue Venture Fund, Mass General Brigham Ventures, and C... |
| 13.09.2023 | Sempre Health Secures $20M to Expand Behavior-Based Healthcare Pricing | Sempre Health
What You Should Know:
– Sempre Health, a San Francisco, CA-based solution for behavior-based healthcare pricing raises $20M in additional funding from three new investors, including Cencora Ventures and Echo Health Ventures. E... |
| 25.05.2023 | Health Investors’ Benchmarks Have Moved in Current Fundraising Environment, Exec Says | Fundraising is always difficult, but perhaps especially so in today’s economic climate. In response, health investors are taking their time in their investments.
“Right now, what we’re seeing is the benchmarks have moved for what investors ... |
| 09.02.2023 | New Children’s Mental Health Startup Emerges from Redesign Health | A new virtual mental health clinic for children launched on Wednesday. The startup, named Fort Health, links pediatric primary care to behavioral care.
“The pediatrician is the first port of call for families looking to find any form of car... |
| 16.08.2021 | Ultromics adds $33M to its AI-enabled cardiac imaging product portfolio | Photo: Kwanchai Lerttanapunyaporn/Getty Images |
| 16.08.2021 | Ultromics Raises $33M for AI-Enabled Echocardiograms to Help Clinicians Diagnose Heart Disease | What You Should Know:
– Today, Ultromics, an Oxford, England-based health-tech startup announced it has raised $33M in Series B funding led by Blue Ventures, the investing arm of Blue Cross Blue Shield, and also includes investment from Opt... |
| 15.06.2021 | Sempre Health Secures $15M for Behavior-Based Healthcare Pricing Platform | What You Should Know:
– Sempre Health, a behavior-based healthcare pricing platform to insurers to offer large prescription copay discounts to members for filling on time (to promote more medication adherence) today announced it has raised ... |
| 14.01.2021 | Lumiata Nabs $14M to Scale Healthcare Specific AI Platform | Lumiata CEO, Dilawar Syed
What You Should Know:
– Healthcare specific AI platform Lumiata raises $14M to scale its enterprise-grade AI platform and invest in customer acquisition and success.
– No-code products speedily predict underwriting... |
| 14.01.2021 | Lumiata raises $14 million for its service to predict healthcare outcomes | Healthcare systems are always looking for ways to save money, and a startup called Lumiata has just raised $14 million to continue building out its service that aims to help them do it.
The company, already backed by Khosla Ventures and Blu... |
| 14.01.2021 | Predictive healthcare analytics company Lumiata raises $14M | The company uses AI to help payers and providers identify and manage high-risk individuals
For payers and providers, healthcare is all about risk. That means, basically, understanding how likely are patients to get sick, how much will that ... |
| 03.12.2020 | Onc.AI raises $6M Financing Round Co-led by Blue Venture Fund and Accomplice | SAN CARLOS, Calif. & WATERLOO, Canada--(BUSINESS WIRE)--Onc.AI, a digital health company developing a novel oncology care management solution, announced today it has closed a $6M financing round co-led by Blue Venture Fund and Accomplic... |
| 23.06.2020 | Somatus Lands $64M to Expand Value-Based Kidney Care Model | What You Should Know:
– Somatus raises $64M in Series C funding led by Longitudinal Capital to fuel the expansion of its value-based kidney care model.
– Somatus will use the funding to continue to scale its model nationally and invest in t... |
| 26.05.2020 | Oncology Analytics Lands $28M to Expand Oncology Capabilities | What You Should Know:
– Oncology Analytics raises $28M in Series C funding led by Baird Capital to expand its oncology-focused capabilities, accelerate real-world data and analytics solutions for health plans, and increase the market share ... |